Very low-density lipoproteins (VLDL) are large lipoproteins made by the liver. They carry triglycerides, and some cholesterol, from the liver to muscles and fat tissue. As their triglycerides are removed by the enzyme lipoprotein lipase, VLDL particles shrink into intermediate-density lipoproteins (IDL) and finally LDL. VLDL and their remnants contain apolipoprotein B and contribute to atherosclerosis. The VLDL level rises and falls mainly with triglycerides.
VLDL cholesterol is rarely measured directly. In most laboratories it is calculated from triglycerides: VLDL-C ≈ TG / 2.2 (mmol/L) or TG / 5 (mg/dL). This is the same assumption used in the Friedewald formula for LDL. It becomes inaccurate when triglycerides are above about 4.5 mmol/L. A related value, remnant cholesterol (total cholesterol − LDL-C − HDL-C), estimates the cholesterol in VLDL and IDL together.
High VLDL reflects increased hepatic production or slower clearance of triglyceride-rich particles. The causes are the same as for high triglycerides: excess calories, sugar and alcohol, abdominal obesity, insulin resistance and type 2 diabetes, fatty liver disease, hypothyroidism, kidney disease, some medicines and genetic dyslipidaemias. Raised remnant cholesterol has been associated with increased risk of ischaemic heart disease in large population studies, independently of LDL.
Low values are usually harmless and accompany low triglycerides. Very low values occur in rare inherited conditions with impaired apoB production (hypobetalipoproteinaemia, abetalipoproteinaemia), malnutrition and severe liver disease.
Treat VLDL together with triglycerides: lose excess weight, cut sugar, refined carbohydrates and alcohol, be physically active and control blood glucose. Medication decisions depend on overall cardiovascular risk and LDL-C or non-HDL-C.
This article is for general information and does not replace a consultation with a doctor. Laboratory results must be interpreted by a physician together with symptoms and other tests.
Published on 13 May 2024